These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 28991483)

  • 1. Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.
    Jayawardena D; Anbazhagan AN; Guzman G; Dudeja PK; Onyuksel H
    Mol Pharm; 2017 Nov; 14(11):3698-3708. PubMed ID: 28991483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule.
    Dulari Jayawardena ; Arivarasu N Anbazhagan ; Priyamvada S; Kumar A; Saksena S; Onyuksel H; Pradeep K Dudeja
    Nanomedicine (Lond); 2020 Oct; 15(25):2459-2474. PubMed ID: 32975467
    [No Abstract]   [Full Text] [Related]  

  • 3. GLP-1 nanomedicine alleviates gut inflammation.
    Anbazhagan AN; Thaqi M; Priyamvada S; Jayawardena D; Kumar A; Gujral T; Chatterjee I; Mugarza E; Saksena S; Onyuksel H; Dudeja PK
    Nanomedicine; 2017 Feb; 13(2):659-665. PubMed ID: 27553076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.
    Sethi V; Rubinstein I; Kuzmis A; Kastrissios H; Artwohl J; Onyuksel H
    Mol Pharm; 2013 Feb; 10(2):728-38. PubMed ID: 23211088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis.
    Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm MC
    Clin Exp Immunol; 2005 Mar; 139(3):411-20. PubMed ID: 15730386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of free radical scavenging activity of vasoactive intestinal peptide in the attenuation of mitochondrial dysfunction to ameliorate dextran sulphate sodium-induced colitis in mice: Implications in ulcerative colitis.
    Spoorthi BC; More SS; Gautham SA; Ghosh S; Saha I; Maiti AK
    J Dig Dis; 2020 Dec; 21(12):711-723. PubMed ID: 33405317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice.
    Vu JP; Million M; Larauche M; Luong L; Norris J; Waschek JA; Pothoulakis C; Pisegna JR; Germano PM
    J Mol Neurosci; 2014 Jan; 52(1):37-47. PubMed ID: 24395090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting breast cancer using pirarubicin-loaded vasoactive intestinal peptide grafted sterically stabilized micelles.
    Eskandari Z; Bahadori F; Yapaoz MA; Yenigun VB; Celikten M; Kocyigit A; Onyuksel H
    Eur J Pharm Sci; 2021 Jul; 162():105830. PubMed ID: 33819623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of neurogenic VIP-mediated relaxation in mouse distal colon with dextran sulfate sodium-induced colitis.
    Kato E; Yamane S; Nomura R; Matsumoto K; Tashima K; Horie S; Saito T; Fujino H; Murayama T
    Pharmacol Res; 2012 Feb; 65(2):204-12. PubMed ID: 21939768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.
    Woo JK; Choi S; Kang JH; Kim DE; Hurh BS; Jeon JE; Kim SY; Oh SH
    BMC Complement Altern Med; 2016 Dec; 16(1):498. PubMed ID: 27912750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.
    Cho EJ; Shin JS; Noh YS; Cho YW; Hong SJ; Park JH; Lee JY; Lee JY; Lee KT
    J Ethnopharmacol; 2011 Jul; 136(3):428-35. PubMed ID: 20573566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis.
    Koo OM; Rubinstein I; Onyüksel H
    Pharm Res; 2011 Apr; 28(4):776-87. PubMed ID: 21132352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin attenuates intestinal inflammation and promotes tissue regeneration.
    Nakamura S; Sho M; Koyama F; Ueda T; Nishigori N; Inoue T; Nakamoto T; Fujii H; Yoshikawa S; Inatsugi N; Nakajima Y
    Scand J Gastroenterol; 2015; 50(9):1094-102. PubMed ID: 25861881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A refined and translationally relevant model of chronic DSS colitis in BALB/c mice.
    Hoffmann M; Schwertassek U; Seydel A; Weber K; Falk W; Hauschildt S; Lehmann J
    Lab Anim; 2018 Jun; 52(3):240-252. PubMed ID: 29192559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.
    Sigalet DL; Wallace LE; Holst JJ; Martin GR; Kaji T; Tanaka H; Sharkey KA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G211-21. PubMed ID: 17395898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
    Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
    J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.